SCHEMBL21297942

SCHEMBL21297942

N#Cc1cc2c(c(C#N)c1C#N)c1c3ccccc3c3ccccc3c1c1cc3ccccc3n21

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ENPP3 O14638 1/20 0.38
MAPK1 P28482 1/20 0.36
DYRK1A Q13627 2/20 0.36
CLK1 P49759 1/20 0.36
MEN1 O00255 3/20 0.35
KMT2A Q03164 3/20 0.35
IMPDH2 P12268 1/20 0.35
ANPEP P15144 1/20 0.34
EGFR P00533 1/20 0.33
SRC P12931 1/20 0.33
CA1 P00915 1/20 0.33
CA2 P00918 1/20 0.33
NCOA3 Q9Y6Q9 1/20 0.32
ALDH1A1 P00352 3/20 0.32
KDM4E B2RXH2 1/20 0.32
MAPT P10636 2/20 0.32
CDK5 Q00535 1/20 0.32
CDK5R1 Q15078 1/20 0.32
HTR2A P28223 1/20 0.32
HTR2C P28335 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21297923 0.87 ENPP3 (0.39) ENPP3MAPK1DYRK1ACLK1MEN1
SCHEMBL21298414 0.85 ENPP3 (0.40) ENPP3MAPK1DYRK1ACLK1MEN1
SCHEMBL21298183 0.84 MAPK1 (0.38) ENPP3MAPK1DYRK1ACLK1MEN1
SCHEMBL21298149 0.84 MAPK1 (0.36) ENPP3MAPK1DYRK1ACLK1MEN1
SCHEMBL21298416 0.82 MAPK1 (0.37) ENPP3MAPK1DYRK1ACLK1MEN1
SCHEMBL21790852 0.81 ENPP3 (0.38) ENPP3MAPK1DYRK1ACLK1MEN1
SCHEMBL21297775 0.80 KDM4E (0.45) MAPK1DYRK1AMEN1KMT2ANCOA3
SCHEMBL21298269 0.77 HSD17B10 (0.40) ENPP3MAPK1KMT2AALDH1A1HTR2A
SCHEMBL21298404 0.76 IMPDH2 (0.33) DYRK1ACLK1MEN1KMT2AIMPDH2
SCHEMBL21790854 0.75 HSD17B10 (0.38) ENPP3MAPK1KMT2AALDH1A1HTR2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230192695-A1 THERMALLY ASSISTED DELAYED FLUORESCENT MATERIALS WITH TRIAD-TYPE MATERIALS UNIV ARIZONA STATE (US) 2023-06-22 US disclosed
US-20210024526-A1 THERMALLY ASSISTED DELAYED FLUORESCENT MATERIALS WITH TRIAD-TYPE MATERIALS UNITED STATES DEPARTMENT OF ENERGY 2021-01-28 US disclosed
US-10851106-B2 Substituted benzo[4,5]imidazo[1,2-F]phenanthridines, dibenzo[I.K]benzo[4,5]imidazo[1,2-F]benzofurophenanthridines and dibenzo[I.K]benzo[4,5]imidazo[1,2-F]benzo[4,5]thienophenanthridines as thermally assisted delayed fluorescent materials ARIZONA BOARD OF REGENTS, ACTING FOR AND ON BEHALF OF ARIZONA STATE UNIVERSITY (US) 2020-12-01 US disclosed
US-20200071330-A1 THERMALLY ASSISTED DELAYED FLUORESCENT MATERIALS WITH TRIAD-TYPE MATERIALS UNITED STATES DEPARTMENT OF ENERGY 2020-03-05 US disclosed
US-10392387-B2 Substituted benzo[4,5]imidazo[1,2-a]phenanthro[9,10-c][1,8]naphthyridines, benzo[4,5]imidazo[1,2-a]phenanthro[9,10-c][1,5]naphthyridines and dibenzo[f,h]benzo[4,5]imidazo[2,1-a]pyrazino[2,3-c]isoquinolines as thermally assisted delayed fluorescent materials ARIZONA BOARD OF REGENTS ON BEHALF OF ARIZONA STATE UNIVERSITY (US) 2019-08-27 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210024526-A1 THERMALLY ASSISTED DELAYED FLUORESCENT MATERIALS WITH TRIAD-TYPE MATERIALS TTPA, TTC14, AAAS ENPP3 2826/4885MAPK1 4535/4885DYRK1A 3633/4885
US-20200071330-A1 THERMALLY ASSISTED DELAYED FLUORESCENT MATERIALS WITH TRIAD-TYPE MATERIALS TTPA, TTC14, AAAS ENPP3 2826/4885MAPK1 4535/4885DYRK1A 3633/4885
US-20230192695-A1 THERMALLY ASSISTED DELAYED FLUORESCENT MATERIALS WITH TRIAD-TYPE MATERIALS TTPA, TTC14, AAAS ENPP3 2826/4885MAPK1 4535/4885DYRK1A 3633/4885
US-10851106-B2 Substituted benzo[4,5]imidazo[1,2-F]phenanthridines, dibenzo[I.K]benzo[4,5]imidazo[1,2-F]benzofurophenanthridines and dibenzo[I.K]benzo[4,5]imidazo[1,2-F]benzo[4,5]thienophenanthridines as thermally assisted delayed fluorescent materials KCNK4, TRPC4, TBRG4 ENPP3 4718/4885MAPK1 2756/4885DYRK1A 2290/4885
US-10392387-B2 Substituted benzo[4,5]imidazo[1,2-a]phenanthro[9,10-c][1,8]naphthyridines, benzo[4,5]imidazo[1,2-a]phenanthro[9,10-c][1,5]naphthyridines and dibenzo[f,h]benzo[4,5]imidazo[2,1-a]pyrazino[2,3-c]isoquinolines as thermally assisted delayed fluorescent materials NT5C, HTR3D, IK ENPP3 4323/4885MAPK1 3360/4885DYRK1A 4102/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.